The efficacy of traditional Chinese medicine as an adjuctive therapy in nasopharyngeal carcinoma: A systematic review and meta-analysis

Journal of B.U.ON.

Volumn 19, Issue 2, 2014, Pages 540-548

  Mao, Cheng Gang ^a   Tao, Ze Zhang ^a   Wan, Li Jia ^b   Han, Ji Bo ^a   Chen, Zhe ^a   Xiao, Bo Kui ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adjunctive therapy; Meta analysis; Nasopharyngeal carcinoma; Systematic review; Traditional Chinese medicine

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE RADIATION SYNDROME; ADVERSE DRUG REACTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHINESE MEDICINE; HUMAN; IMMUNOREGULATION; KARNOFSKY PERFORMANCE STATUS; META ANALYSIS; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CARCINOMA; OUTCOME ASSESSMENT; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT DURATION;

HUMANS; MEDICINE, CHINESE TRADITIONAL; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; QUALITY OF LIFE;

EID: 84904156171     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Jeannel D, Bouvier GAH. Nasopharyngeal carcinoma: an epidemiological approach to carcinogenesis. Cancer Surv 1999;33:125-55.
2. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Hui EP, Leung SF, Au JS et al. Lung metastasis alone in nasopharyngeal carcinoma : a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Cancer 2004;101:300-306. (Pubitemid 38890833)
4. Lee AW, Sze WM, Au JS et al. Treatment results for nasopharyngeal carcinoma in the modem era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2005;61:1107-1116. (Pubitemid 40340904)
5. Lee N, Xia P, Quivey JM et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12-22. (Pubitemid 34465802)
6. Barnes PM, Powell-Griner E, McFann K et al. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004;343:1-19.
7. Sparber A, Bauer L, Curt G et al. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum 2000;27:623-630.
8. Molassiotis A, Fernadez-Ortega P, Pud D et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005; 16:655-663. (Pubitemid 40613334)
9. Cui Y, Shu XO, Gao Y et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat 2004;85:263-270. (Pubitemid 38987261)
10. Legal status of traditional medicine and complementary/alternative medicine: a worldwide review. Geneva: World Health Organization; 2001.
11. Cho WC. Supportive cancer care with Chinese medicine. New York, NY: Springer, 2010.
12. Wang CY, Li GS, Huang HX et al. Clinical Observation on Treatment of 75 Mid-late Stage Cancer Patients with Yanshu Injection. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006;26:681-684.
13. Huang GX, Zhao C, Han F et al. Clinical Study in Prophylactic Use of Chinese Medicine to Prevent Chemoradiotherapy Induced Mucositis in Nasopharyngeal Carcinoma. Chin J Cancer 2003:22:1084-1087.
14. Xie FY, Huang HY, Hu JZ et al. Observation on Effect of Radiotherapy and Antike Capsule Combination Therapy in Treating Nasopharyngeal cancer Patients. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001;21:888-890.
15. WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization, 1979.
16. Jadad AR, Moore RA. Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12. (Pubitemid 26120810)
17. Julian H, Sally G. Cochrane handbook for systematic reviews of interventions 5.1.0. Available online at http://www.cochrane-handbook.org/.
18. Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188. (Pubitemid 17189972)
19. Zhu XD, Wang AY, Wang SF et al. Clinical Study on Effect of Combined Treatment with Shenlong Oral Liquid and Radiotherapy in Treating Nasopharyngeal Carcinoma. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000;20:818-820.
20. Chen S. Clinical eficacy of AiDi injection combined with radiotherapy for nasopharyngeal carcinoma. Mod Oncol 2005;13:830-831.
21. Zhou TC, Lin XD, Song XL et al. Clinical observation of selaginella combined with radiotherapy for terminal nasopharyngeal carcinoma. Chin J Cancer Prev Treat 2006;13:772-773.
22. Wu XD, Shi JJ, Liu JQ et al. Clinical Observation on Combined Treatment with Traditional Chinese Medicine and Radiotherapy in Treating Nasopharyngeal Carcinoma. Journal of Guangzhou University of Traditional Chinese Medicine 2003; 20:42-45.
23. Zou YH, Liu XM,Tan LR et al. Clinical Study on Chinese Herbal Medicine for Prevention and Treatment of 60 Cases of Acute Radiation Oropharyngeal Inflammation of Nasopharyngeal Carcinoma. J Tradit Chin Med 2005;46:520-522.
24. Zhou TC, Lin XD, Song XL et al. Long-term treatment outcome of radiation combined with the Chinese herbal selaginella for terminal Nasopharyngeal Carcinoma. Chin Hosp Pharm J 2008;28:2122-2123.
25. Tang HY, Huang YC et al. Chinese medicine as prevention and treatment for radiation-induced oral mucositis by 5-fluorouracil in treating nasopharyngeal carcinoma. Acta Med Sin 2012;25:326-328.
26. Wang F, Wang YH. Clinical effects of acupuncture and moxibustion therapy plus Chinese herbal preparation in nasopharyngeal carcinoma patients undergoing radiotherapy. China Mod Doctor 2012;50:78-81.
27. Yuan J, Zhang Z,Xiao JY. Efficacy of radiotherapy combined with traditional Chinese medicine (TCM) in NPC patients. Bull Hunan Med Univ 2000;25:254-256.
28. Zhou YJ, Shen HM, Huang J. The Clinical Observation of Modified Decoction for Letting out Toxic Material on Improving Quality of Life of Patients with Nasopharyngeal Carcinoma Treated by Radiotherapy. J Basic Clin Oncol 2012;25:320-322.
29. Jing Y, Tang AZ, Liu J et al. Effects of Selaginella doederleinii on human nasopharyngeal carcinoma TW03 cells in vitro and its mechanism. Zhong Yao Cai 2009;32:1864-1867.
30. Kang M, Tang A, Liang G. The inhibitory role of zhongjiefeng extracts, on apoptosis and telomerase activity of nasopharyngeal carcinoma cell line xenograft in nude mice. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2008;22:1132-1137.
31. Dai Z, Huang D, Shi J et al. Apoptosis inducing effect of tanshinone II(A) on human nasopharyngeal carcinoma CNE cells. Zhongguo Zhong Yao Za Zhi 2011;36:2129-2133.
32. Li S, Zeng XT, Ruan XL et al. Simultaneous transurethral resection of bladder cancer and prostate may reduce recurrence rates: A systematic review and meta-analysis. Exp Ther Med 2012;24:685-692.
33. Zhong LL, Chen HY, Cho WC et al. The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis. Complement Ther Med 2012;20:240-252.
34. Cho WC, Chen HY. Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis. Expert Opin Investig Drugs 2009; 18:617-635.
35. Li SG, Chen HY, Ou-Yang CS et al. The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis. PLoS One 2013;8 :e57604.
36. Cho WC. Chinese versus Western medicine. In: Schwab M (Ed): Encyclopedia of Cancer, vol. 3(2nd Edn). New York, NY: Springer, 2009, pp 652-654.
37. Kawakita T, Nakai S, Kumazawa Y et al. Induction of interferon after administration of traditional Chinese medicine, xiao-chai-hu-tang (shosaiko-to). Int J Immunopharmacol 1990;12:515-521. (Pubitemid 20263597)
38. Horie Y, Kato K, Kameoka S et al. Bu ji (hozai) for treatment of postoperative gastric cancer patients. Am J Chin Med 1994;22:309-319.
39. Lin SY, Liu LM, Wu LC. Effects of Shenmai injection on immune function in stomach cancer patients after chemotherapy. Zhongguo Zhong Xi Yi Jie He Za Zhi 1995;15:451-453.
40. Block KI, Mead MN. Immune system effects of echinacea, ginseng, and astragalus: a review. Integr Cancer Ther 2003;2:247-267. (Pubitemid 37138611)
41. Cho WC, Leung KN. In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett 2007;252:43-54. (Pubitemid 46734552)
42. Cho WC, Leung KN. In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. J Ethnopharmacol 2007;113:132-141. (Pubitemid 47077858)
43. Tarhan O, Alacacioglu A, Somali I et al. Complementary-alternative medicine among cancer patients in the western region of Turkey. JBUON 2009;14:265-269.
44. Tuna S, Dizdar O, Calis M. The prevalence of usage of herbal medicines among cancer patients. JBUON 2013;18:1048-1051.
45. Flower A, Witt C, Liu JP et al. Guidelines for randomised controlled trials investigating Chinese herbal medicine. J Ethnopharmacol 2012;140:550-554.